Search Within

Gastrointestinal Oncology Service

Formats
  1. Journal Article (2350)
  2. Meeting Abstract (1870)
  3. Review (150)
  4. Book Section (127)
  5. Editorial (100)
  6. Guidelines (39)
  7. Correspondence (34)
  8. Conference Paper (24)
  9. Miscellaneous (23)
  10. Research Letter (17)
  11. Book Whole (12)
Groups
  1. Solid Tumor Oncology Division (4746)
  2. Department of Medicine (4744)
  3. Center for Pancreatic Cancer Research (2313)
  4. Surgery (1066)
  5. Survivorship Research (1014)
  6. Epidemiology and Biostatistics (842)

More Groups

People
  1. Eileen O'Reilly (803)
  2. Leonard Saltz (796)
  3. Ghassan Abou-Alfa (583)
  4. Nancy Kemeny (545)
  5. David Kelsen (538)
  6. David Ilson (443)

More People

Years
  1. 2025 (221)
  2. 2024 (309)
  3. 2023 (362)
  4. 2022 (346)
  5. 2021 (345)
  6. 2020 (326)

More Years

Publications
  1. Journal of Clinical Oncology (1290)
  2. Annals of Oncology (331)
  3. Annals of Surgical Oncology (148)
  4. Cancer (128)
  5. Clinical Cancer Research (107)
  6. Cancer Research (94)

More Publications

Publishers
  1. American Society of Clinical Oncology (1379)
  2. Oxford University Press (462)
  3. Elsevier Inc. (408)
  4. Springer (321)
  5. American Association for Cancer Research (281)
  6. Wiley Blackwell (241)

More Publishers

Results (4746)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Trifluridine/tipiracil outcomes in third- or later lines versus placebo in metastatic gastric cancer treatment: An exploratory subgroup analyses from the TAGS study
    Meeting Abstract

    Tabernero, J.; Shitara, K.; Zaanan, A.; Doi, T.; Lorenzen, S.; Van Cutsem, E.; Fornaro, L.; Catenacci, D. V. T.; Fougeray, R.; Vera, S. R. M.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • KEYNOTE-177: Phase III randomized study of pembrolizumab versus chemotherapy for microsatellite instability-high advanced colorectal cancer
    Meeting Abstract

    Shiu, K. K.; Andre, T.; Kim, T. W.; Jensen, B. V.; Jensen, L. H.; Punt, C. J. A.; Smith, D. M.; Garcia-Carbonero, R.; Benavides, M.; Gibbs, P.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Exposure-response (E-R) efficacy and safety (E-S) analyses of tremelimumab as monotherapy or in combination with durvalumab in patients (pts) with unresectable hepatocellular carcinoma (uHCC)
    Meeting Abstract

    Song, X.; Kelley, R. K.; Khan, A.; Standifer, N.; Krishna, R.; Liu, L.; Wang, K.; Green, M.; McCoon, P.; Negro, A.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • PULSE: A randomized phase II open label study of panitumumab rechallenge versus standard therapy after progression on anti-EGFR therapy in patients with RAS wild-type metastatic colorectal cancer (mCRC)
    Meeting Abstract

    Strickler, J. H.; Ou, F. S.; Bekaii-Saab, T. S.; Parseghian, C. M.; Cercek, A.; Ng, K.; Sanchez, F. A.; Bruggeman, S.; Larson, J. J.; Finley, G. G.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • A phase III, double-blind, randomized study of nivolumab (NIVO) and ipilimumab (IPI), nivo monotherapy or placebo plus transarterial chemoembolization (TACE) in patients with intermediate-stage hepatocellular carcinoma (HCC)
    Meeting Abstract

    Sangro, B.; Harding, J. J.; Johnson, M.; Palmer, D. H.; Edeline, J.; Abou-Alfa, G. K.; Cheng, A. L.; Decaens, T.; El-Khoueiry, A. B.; Finn, R. S.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • POLO: Radiologic assessment of the impact of maintenance olaparib in patients (pts) with metastatic pancreatic cancer (mPaC)
    Meeting Abstract

    Schwartz, L. H.; Kindler, H. L.; Hammel, P.; Reni, M.; Van Cutsem, E.; Macarulla, T.; Hall, M. J.; Park, J. O.; Hochhauser, D.; Arnold, D.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • A phase I study of LY3410738, a first-in-class covalent inhibitor of mutant IDH1 in cholangiocarcinoma and other advanced solid tumors
    Meeting Abstract

    Pauff, J. M.; Papadopoulos, K. P.; Janku, F.; Turk, A. A.; Goyal, L.; Shroff, R. T.; Shimizu, T.; Ikeda, M.; Azad, N. S.; Cleary, J. M.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Genomic characterization of a comprehensive collection of esophagogastric cancer patient-derived xenografts
    Meeting Abstract

    Moy, R. H.; Mattar, M.; Molena, D.; Strong, V. E.; Jones, D. R.; Coit, D. G.; Tang, L.; Maron, S. B.; Hechtman, J. F.; de Stanchina, E.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • A phase IIb, open-label, single-arm study of zanidatamab (ZW25) monotherapy in subjects with advanced or metastatic HER2-amplified biliary tract cancers
    Meeting Abstract

    Pant, S.; Ducreux, M.; Harding, J. J.; Javle, M. M.; Oh, D. Y.; Wasan, H. S.; Fortenberry, A.; Josephson, N. C.; Mwatha, A.; Wang, K.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Durvalumab (D) and PET-directed chemoradiation (CRT) after induction FOLFOX for esophageal adenocarcinoma
    Meeting Abstract

    Ku, G. Y.; Wu, A. J. C.; Sihag, S.; Park, B. J.; Jones, D. R.; Gu, P.; Maron, S. B.; Sugarman, R.; Chalasani, S. B.; Shcherba, M.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save